VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CANF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CANFCan-Fite BioPharma Ltd.
$1.81$2M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCANFQuarterly Cash Flow

Can-Fite BioPharma Ltd. (CANF) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Can-Fite BioPharma Ltd. (CANF) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

CANF Cash Flow Statement

Quarterly statement

CANF Cash Flow Statement

Can-Fite BioPharma Ltd. (CANF) cash flow statement — 15-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-2.66M-2.66M-2.1M-2.1M-2.38M-2.38M-1.8M-1.8M-2.02M-2.02M0-95K95K0263K-135K135K000
Operating CF Margin %-2630.69%-2630.69%-2067.49%-2067.49%-2352.48%-2352.48%-1005.87%-1005.87%-1277.21%-1277.21%--48.47%48.47%-133.5%-66.18%66.18%---
Operating CF Growth %-11.83%-11.83%-16.55%-16.55%-17.74%-17.74%--1795.26%-2224.21%--100%29.63%-29.63%-------
Net Income-2.3M-2.3M-2.48M-2.48M-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.55M-3.02M-2.53M-2.19M-2.43M-4.12M-3.4M
Depreciation & Amortization50050050050011.5K11.5K3K3K5005000000000000
Stock-Based Compensation46K46K44.5K44.5K125.5K125.5K84.5K84.5K96.5K96.5K261K-95K95K0263K-135K135K0466K-234K
Deferred Taxes00000000000000000000
Other Non-Cash Items-353K-353K-93.5K-93.5K203.5K203.5K-194K-194K185.5K185.5K1.39M1.86M1.57M2.55M2.76M2.66M2.06M2.43M3.65M3.63M
Working Capital Changes-50K-50K426K426K-278.5K-278.5K267.5K267.5K-322K-322K0000000000
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables00000000000000000000
Cash from Investing-500.5K-500.5K-1.5M-1.5M1.5M1.5M-1.5M-1.5M2.25M2.25M0000000000
Capital Expenditures-500-500-500-500-500-500-500-500-2K-2K0000000000
CapEx % of Revenue0.5%0.5%0.49%0.49%0.5%0.5%0.28%0.28%1.27%1.27%----------
Acquisitions00000000000000000000
Investments--------------------
Other Investing-500K-500K-1.5M-1.5M1.5M1.5M-1.5M-1.5M2.25M2.25M0000000000
Cash from Financing1.89M1.89M3.14M3.14M1.69M1.69M3.36M3.36M000000000000
Debt Issued (Net)00000000000000000000
Equity Issued (Net)00000000000000000000
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing1.89M1.89M3.14M3.14M1.69M1.69M3.36M3.36M000000000000
Net Change in Cash0000000-4.72M4.72M00-95K95K0263K-135K135K000
Free Cash Flow-2.66M-2.66M-2.1M-2.1M-2.38M-2.38M-1.8M-1.8M-2.02M-2.02M0-95K95K0263K-135K135K000
FCF Margin %-2631.19%-2631.19%-2067.98%-2067.98%-2352.97%-2352.97%-1006.15%-1006.15%-1278.48%-1278.48%--48.47%48.47%-133.5%-66.18%66.18%---
FCF Growth %-11.82%-11.82%-16.55%-16.55%-17.65%-17.65%--1795.79%-2226.31%--100%29.63%-29.63%-------
FCF per Share-0.72-0.72-0.01-0.97-0.21-0.21-0.21-0.21-0.33-0.33--0.020.02-0.10-0.050.05---
FCF Conversion (FCF/Net Income)1.15x1.15x0.85x0.85x0.97x0.97x0.92x0.92x1.02x1.02x-0.05x-0.06x--0.09x0.06x-0.06x---
Interest Paid00000000000000000000
Taxes Paid00000000000000000000